Here are relevant reports on : address-validation-market
-
Drug Discovery Technologies Market by Product (Instruments, Reagents, Software), Technology (HTS, NGS, PCR, AI-based, Lab-on-chip), Process (Target Identification, Validation, Lead Optimization), Therapeutic Area (Oncology, CVD) - Global Forecast to 2030
The Drug Discovery Technologies market, valued at US$28.61 billion in 2024, stood at US$30.58 billion in 2025 and is projected to advance at a resilient CAGR of 11.0% from 2025 to 2030, culminating in a forecasted valuation of US$51.51 billion by the end of the period. The growth of the drug discovery technologies market is driven by the broader use of advanced screening platforms and rising demand for biologics, cell and gene therapies, and RNA-based drugs.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Digital Twin TIC Market Size, Share & Trends by Virtual Model Validation, Cyber-Physical Testing, Compliance Certification, Edge Integration, and Industry Standards - Global Forecast to 2032
The global Digital Twin TIC market size, share is expanding rapidly as industries increasingly rely on virtual replicas of physical assets. In 2025, the global market was valued at USD 1.2 billion. Driven by stringent regulations surrounding virtual model validation and industrial automation, the market is projected to reach USD 5.1 billion by 2032, reflecting a robust compound annual growth rate (CAGR) of 23.0% from 2026 to 2032. As organizations scale their digital transformation initiatives, verifying the accuracy, security, and interoperability of these complex virtual systems has become paramount.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Biomarker Technologies Market by Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry, Immunoassay, Liquid Biopsy (ddPCR, DHPLC)), Research Area (Proteomics, Lipidomics), Application (Biomarker Validation, Biomarker Discovery) & Geography
The global biomarker technologies market is projected to grow at a CAGR of 9.7%. The key players in the biomarker technologies market are Thermo Fisher Scientific (US), Agilent Technologies (US), Roche (Switzerland), Danaher Corporation (US), Waters Corporation (US), Shimadzu Corporation (Japan), and Bio-Rad Laboratories (US).
- Published: May 2018
- Price: $ 15000
- TOC Available:
-
CRISPR Market by Offering (Product (Kits, Enzymes, Libraries), Service (gRNA Synthesis, Cell Line Development, Screening, Validation)), Application (Drug Discovery, Development, Agriculture) Competitive Landscape, Company Profiles -Global Forecast to 2030
The global CRISPR market, valued at US$2.90 billion in 2024, stood at US$3.21 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$5.47 billion by the end of the period. The growing demand for CRISPR-based gene therapies, followed by advancements in CRISPR technology, and the rising government and private investments in CRISPR technology support the market growth. The development of new vaccines for the treatment of genetic diseases and the expansion of industrial and agricultural applications are presenting strong growth opportunities for CRISPR in the coming years.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Chemoinformatics Market by Application (Chemical Analysis (Chemical Databases, Chemo Metrics, Molecular Modelling), Drug Discovery (High Throughput Screening, Lead Identification and Optimization, QSAR/QSPR), Drug Validation) - Global Forecast to 2023
Growth of the chemoinformatics market is primarily driven by innovations and advancements in the drug development process, advances in the computer technology, increased demand of personalized medicine. On the other hand, cost associated with the chemoinformatics software is one of the major factors restraining the growth of this market. Whereas emerging markets are expected to provide significant growth opportunities in this market.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Sterilization Services Market by Method (Electron Beam, EtO, Steam, Gamma, X-Ray, Hydrogen Peroxide), Type (Contract Sterilization, Validation Services), Mode of Delivery (Off-Site, On-Site), End User & Region - Global Forecast to 2030
The global sterilization services market, valued at US$3.52 billion in 2024, stood at US$3.75 billion in 2025 and is projected to advance at a resilient CAGR of 7.9% from 2025 to 2030, culminating in a forecasted valuation of US$5.49 billion by the end of the period. The market for sterilization services is growing due to the rising prevalence of hospital-acquired infections (HAIs), increasing surgical procedure volumes, heightened focus on food sterilization to combat foodborne illnesses, and the growing trend of outsourcing sterilization to specialized contract service providers.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Laboratory Equipment Services Market by Service Type (Installation, Repair, Breakdown, and Maintenance; Calibration; Qualification & Validation; Preventive Maintenance Services; Training, Education & Certification Services; Others), Service Provider (OEM Services, Third Party Service Providers, Distributor Led Services), Equipment Type (Analytical Equipment, General Equipment, Specialty Equipment, Support Equipment), Contract Type (Gold Support Plan, Silver Support Plan, Platinum Support Plan, Customized Support Plan, Other Support Plans) - Global Forecast to 2030
The laboratory equipment services market, valued at US$20.5 billion in 2024, stood at US$23.5 billion in 2025 and is projected to advance at a resilient CAGR of 15.0% from 2025 to 2030, culminating in a forecasted valuation of US$54.5 billion by the end of the period. The market growth is driven by rising regulatory and quality compliance requirements.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Drug Discovery Services Market by Process (Target Validation, Hit-to-Lead, Lead Optimization), Type (Chemistry, Biology), Therapeutic Area (Oncology, Neurology, Infectious, CVD), Drug Type (Small Molecules, Biologics), End User - Global Forecast to 2030
The global drug discovery services market, valued at US$14.89B in 2024, is forecasted to grow at a 10.7% CAGR, reaching US$16.36B by 2025 and US$27.23B by 2030. Growing awareness about personalized medicines and targeted therapies, a vast patient population, and emerging middle-class population are enhancing market penetration in the Asia Pacific region.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
AI Training Dataset Market by Software (Data Collection Tools, Data Annotation Software, Off-the-Shelf Datasets), Services (Data Validation Services, Dataset Marketplaces), Data Modality (Text, Image, Video, Audio, Multimodal) - Global Forecast to 2029
The AI training dataset market size is projected to reach USD 9.58 billion in 2029, and is set to grow at a CAGR of 27.7% during the forecast period, . The major players in the AI training dataset market include Scale AI (US), Appen (Australia), Lionbridge Technologies (US), AWS (US), and Sama (US), along with SMEs and startups such as Snorkel AI (US), V7 Labs (UK), Alegion (US), Toloka AI (US), and iMerit (US).
- Published: October 2024
- Price: $ 4950
- TOC Available:
-
AI Testing & Certification Service Market Size, Share & Trends by Model Validation, Bias and Fairness Auditing, Red Teaming, Conformity Assessment, Data Quality Testing, and Post-Deployment Monitoring - Global Forecast to 2032
The global AI testing and certification service market is estimated at USD 4.8 billion in 2025 and is projected to reach USD 22.6 billion by 2032, growing at a CAGR of approximately 24.6% between 2026 and 2032. Key players include SGS SA, Bureau Veritas, Intertek, TÜV SÜD, TÜV Rheinland, DEKRA, DNV, UL Solutions, Eurofins Scientific, BSI Group, and AI-native specialists such as Protect AI, Gray Swan AI, and Promptfoo.
- Published: September 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
